Zooming From Zero To $400 Million: The Making of Mankind Pharma - India’s Fastest Growing Company
This article was originally published in The Pink Sheet Daily
Executive Summary
The head of India’s fastest-rising pharma company may be unconventional, but his willingness to take risks and do business differently has set the company on an upward trajectory.
You may also be interested in...
Global Pharma Bidders May Queue Up For A Slice Of Mankind Pharma And Scorching 25 Percent Growth
Indian Investors Turn Cautious On Compliance Concerns
A rising number of enforcement actions by major drug regulators like the U.S. FDA is slowly making investors cautious about the longer term repercussions on earnings of Indian drug makers.
Lee Takes India Compulsory License Fight To Saxagliptin
In a bold move, little known Indian drug firm Lee Pharma has applied for a compulsory license for saxagliptin in India, contending that AstraZeneca sells the diabetes drug at an exorbitant local price and that it is not being made sufficiently available. Lee also says that the originator has not responded to calls to collaborate.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: